Life Science

Antibiotics Market Analysis and Global Forecast 2023-2033

$ 1,390.00 – $ 5,520.00

Antibiotics Market Research Report: By Class (Beta Lactam & Beta Lactamase Inhibitors, Quinolone, Macrolide, Others), By Drug Origin (Natural, Semisynthetic, Synthetic), By Spectrum of Activity (Broad-spectrum Antibiotic, Narrow-spectrum Antibiotic), and by Region — Forecast till 2033.

Page: 167

Report Published on: October 24, 2024
$ 3,470.00
$ 5,520.00
$ 1,390.00
Report Code: EBI74417 Categories: ,
Description

Antibiotics Market Overview

The Antibiotics Market Size is expected to reach USD 41.65 Billion by 2033. The Antibiotics industry size accounted for USD 32.54 Billion in 2023 and is expected to expand at a compound annual growth rate (CAGR) of 1.65% from 2023 to 2033. The antibiotics market refers to the global market for pharmaceutical products designed to combat various bacterial infections. It includes a wide range of antibacterial drugs, such as penicillins, cephalosporins, macrolides, fluoroquinolones, and tetracyclines. The market is driven by the increasing prevalence of infectious diseases and the need for effective treatments. Broad-spectrum antibiotics, like amoxicillin and levofloxacin, are particularly significant in this market. The market is expected to grow at a CAGR of 5.67% from 2023 to 2028, driven by factors like heightened awareness of disease detection and treatment, regulatory designations, and ongoing clinical trials to combat antibiotic resistance

Global Antibiotics Market Synopsis

Antibiotics MarketCOVID-19 Impact Analysis

The COVID-19 pandemic has led to supply chain disruptions leading to supply shortages or lower demand in the Antibiotics market. The travel restrictions and social-distancing measures have resulted in a sharp drop in consumer and business spending and this pattern is to continue for some time. The end-user trend and preferences have changed due to the pandemic and have resulted in manufacturers, developers, and service providers to adopt various strategies to stabilize the company.

Global Antibiotics Market Dynamics

The major factors that have impacted the growth of Antibiotics are as follows:

Drivers:

⮚      Increasing Burden of Infectious Diseases

The increasing burden of infectious diseases is a significant driver of the antibiotics market. The growing prevalence of infectious diseases globally is leading to a higher demand for effective treatments, which in turn is driving the growth of the antibiotics market. The market is expected to reach $50,374 million by 2025, growing at a CAGR of 2.1% from 2018 to 2025

Restraint:

  • High Research and Development Costs

The high costs associated with researching and developing new antibiotics is a significant barrier to market growth. It can take years and millions of dollars to bring a new antibiotic to market, which discourages investment in this area

Opportunity:

⮚      Introduction of Novel Combination Therapies

The introduction of novel combination therapies to treat antibiotic-resistant microbial infections offers opportunities for market growth. These therapies can help address the challenge of antimicrobial resistance and provide effective treatments for various bacterial infections.

Antibiotics Market Segment Overview

By Class

Antibiotics Market class analysisBased on the Class, the market is segmented based on Beta Lactam & Beta Lactamase Inhibitors, Quinolone, Macrolide, Others. Beta-lactam antibiotics, which include penicillins and cephalosporins, are the most widely used class of antibiotics due to their broad spectrum of activity and effectiveness against a wide range of bacteria

By Drug Origin

Based on the Drug Origin, the market has been divided into Natural, Semisynthetic, Synthetic.  Semisynthetic antibiotics, which are derived from natural antibiotics but have improved coverage and effectiveness against a wide range of organisms, accounted for a significant share of the market in 2023

By Spectrum of Activity

Based on Spectrum of Activity, the market has been divided into Broad-spectrum Antibiotic, Narrow-spectrum Antibiotic. The antibiotics market has been segmented based on the spectrum of activity, with broad-spectrum antibiotics dominating the market. Broad-spectrum antibiotics, which act against both Gram-positive and Gram-negative bacteria, account for a significant share of the market due to their versatility and effectiveness in treating a wide range of infections

Global Antibiotics Market Regional Analysis

Based on region, the market has been divided into North America, Europe, Asia-Pacific, the Middle East & Africa, and Latin America. The area of North America is anticipated to dominate the market for the usage of Antibiotics, followed by those in Asia-Pacific and Europe.

Global Antibiotics Market Regional AnalysisAntibiotics North America Market

North America dominates the Antibiotics market due to several factors. The North America antibiotics market is expected to grow at a CAGR of 2.9% from 2023 to 2028. The market is driven by the increasing demand for antibiotics due to the high burden of infectious diseases and the growing aging population. The United States dominates the market due to the higher demand for meat and the mass production of livestock. The usage of Veterinary Feed Directive (VFD) drugs requires authorization by a licensed veterinarian, which has hampered market growth.

Antibiotics Asia Pacific Market

The Asia-Pacific region has been witnessing remarkable growth in recent years. The Asia-Pacific antibiotics market is expected to grow at a CAGR of 4.2% from 2023 to 2028, driven by the increasing prevalence of infectious diseases, growing demand for antibiotics in developing countries, and government initiatives to develop novel therapies for treating drug-resistant infections. The market was valued at $11,591.97 million in 2019 and is expected to reach $15,784.01 million by 2027. China and India are significant contributors to the market growth due to their large populations and increasing demand for meat. The market is expected to be driven by the growing adoption of strategies such as mergers and acquisitions by key players and rising investments in research and development

Competitive Landscape

The competitive landscape includes key players (tier 1, tier 2, and local) having a presence across the globe. Companies such as Abbott Laboratories, Allergan Plc, HOFFMANN-LA ROCHE LTD., GlaxoSmithKline Plc, and Merck & Co. Inc are some of the leading players in the global Antibiotics Industry. These players have adopted partnership, acquisition, expansion, and new product development, among others as their key strategies.

Key Market Players:

  • Abbott Laboratories
  • Allergan Plc
  • HOFFMANN-LA ROCHE LTD.
  • GlaxoSmithKline Plc
  • Merck & Co. Inc
  • Mylan N.V
  • Novartis International AG
  • Pfizer Inc
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi

Key development:

In September 2022, Abbott Laboratories reported its second-quarter results, which included a 5.32% increase in annual research and development expenses to $2.888 billion. The company also raised its full-year 2022 EPS guidance, projecting at least $3.50 in diluted EPS on a GAAP basis Scope of the Report

Global Antibiotics Market, by Class

  • Beta Lactam & Beta Lactamase Inhibitors
  • Quinolone
  • Macrolide
  • Others

 Global Antibiotics Market, by Drug Origin

  • Natural
  • Semisynthetic
  • Synthetic

Global Antibiotics Market, by Spectrum of Activity

  • Broad-spectrum Antibiotic
  • Narrow-spectrum Antibiotic

 Global Antibiotics Market, by Region

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Benelux
    • Nordic
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • Indonesia
    • Austalia
    • Malaysia
    • India
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • South Africa
    • Rest of Middle East & Africa

 

Parameters Indicators
Market Size 2033: $41.65 Billion
CAGR 1.65% CAGR (2023-2033)
Base year 2022
Forecast Period 2023-2033
Historical Data 2021
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Key Segmentations Class, Drug Origin, Spectrum of Activity
Geographies Covered North America, Europe, Asia-Pacific, Latin America, Middle East, Africa
Key Vendors Abbott Laboratories, Allergan Plc, HOFFMANN-LA ROCHE LTD., GlaxoSmithKline Plc, Merck & Co. Inc, Mylan N.V, Novartis International AG, Pfizer Inc, Teva Pharmaceutical Industries Ltd., Sanofi
Key Market Opportunities • New product launches and R&D Amongst major key Players
Key Market Drivers • Increasing approval of antibiotic drugs.The rise in the incidence of chronic and infectious diseases.Growing investment opportunities by biotech companies in research & development.Development of generic drugs

 

REPORT CONTENT BRIEF:

  • High-level analysis of the current and future Antibiotics Industry trends and opportunities
  • Detailed analysis of current market drivers, restraining factors, and opportunities analysis in the future
  • Historical market size for the year 2021, and forecast from 2023 to 2033
  • Antibiotics market share analysis for each segment
  • Competitor analysis with a comprehensive insight into its product segment, financial strength, and strategies adopted.
  • Identifies key strategies adopted by the key players including new product development, mergers and acquisitions, joint ventures, collaborations, and partnerships.
  • To identify and understand the various factors involved in the global Antibiotics market affected by the pandemic
  • To provide year-on-year growth from 2022 to 2033
  • To provide short-term, long-term, and overall CAGR comparison from 2022 to 2033.
  • Provide Total Addressable Market (TAM) for the Global Antibiotics Market.

For more details mail us at

Ask a question / additional requirement

Press Release

Frequently Asked Questions (FAQ)

The Antibiotics Market is expected to grow at a compound annual growth rate (CAGR) of 1.65% from 2023 to 2033.

The Asia-Pacific region has the highest growth rate in the Antibiotics Market, driven by increasing prevalence of infectious diseases and rising government initiatives.

North America holds the largest share of the Antibiotics Market, due to a high burden of infectious diseases and a growing aging population.

Key players in the Antibiotics Market include Abbott Laboratories, Allergan Plc, Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, and Merck & Co. Inc.

Yes, we offer 16 hours of analyst support to solve the queries

Yes, we provide regional as well as country-level reports. Other than this we also provide a sectional report. Please get in contact with our sales representatives.

Table of Content

Table of Content

CHAPTER 1.                 Executive Summary

CHAPTER 2.                 Scope of the Study

2.1.        Market Definition

2.2.        Market Scope & Segmentation

2.2.1.         Objective of Report

CHAPTER 3.                 Evolve BI Methodology

3.1.        Data Collection & Validation Approach

3.2.        Market Size Estimation and Forecast

CHAPTER 4.                 Exclusive Analysis

4.1.        Market Opportunity Score

4.1.1.         Class Segement – Market Opportunity Score

4.1.2.         Drug Origin Segment – Market Opportunity Score

4.1.3.         Spectrum of Activity Segment – Market Opportunity Score

4.2.        Key Market Influencing Indicators

CHAPTER 5.                 Market Insights and Trends

5.1.        Value Chain Analysis

5.1.1.         Raw Material

5.1.2.         Manufacturing Process

5.1.3.         Distribution Channel

5.1.4.         End User

5.2.        Porter’s Five Forces Analysis

5.2.1.         Bargaining Power of Buyers

5.2.2.         Bargaining Power of Suppliers

5.2.3.         Threat of New Entrant

5.2.4.         Threat of Substitute

5.2.5.         Industry Rivalry

5.3.        COVID-19 Impact and Post COVID Scenario on Antibiotics Market

5.3.1.         Impact of COVID-19

5.3.2.         Government Support and Industry Revival Policies

5.3.3.         Measures Taken by Companies to Mitigate Negative Impact

5.3.4.         Post COVID Trend

CHAPTER 6.                 MArket Dynamics

6.1.        Introduction

6.2.        Drivers

6.2.1.         Driver 1

6.2.2.         Driver 2

6.2.3.         Driver 3

6.3.        Restraints

6.3.1.         Restraint 1

6.3.2.         Restraint 2

6.4.        Opportunity

6.4.1.         Opportunity 1

CHAPTER 7.                 Global Antibiotics Market, By Class

7.1.        Introduction

7.1.1. Beta Lactam & Beta Lactamase Inhibitors

7.1.2. Quinolone

7.1.3. Macrolide

7.1.4. Others

CHAPTER 8.                 Global Antibiotics Market, By Drug Origin

8.1.        Introduction

8.1..1. Natural

8.1.2. Semisynthetic

8.1.3. Synthetic

8.1.4. Drug Origin

CHAPTER 9.                 Global Antibiotics Market, By Spectrum of Activity

9.1.        Introduction

9.1.1. Broad-spectrum Antibiotic

9.1.2. Narrow-spectrum Antibiotic

CHAPTER 10.               Global Antibiotics Market, By Region

10.1.     Introduction

10.2.     NORTH AMERICA

10.2.1.      North America: Market Size and Forecast, By Country, 2023 – 2033 ($ Million)

10.2.2.      North America: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)

10.2.3.      North America: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)

10.2.4.      North America: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)

10.2.5.      US

10.2.5.1.       US: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)

10.2.5.2.       US: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)

10.2.5.3.       US: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)

10.2.6.      CANADA

10.2.6.1.       Canada: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)

10.2.6.2.       Canada: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)

10.2.6.3.       Canada: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)

10.2.7.      MEXICO

10.2.7.1.       Mexico: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)

10.2.7.2.       Mexico: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)

10.2.7.3.       Mexico: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)

10.3.     Europe

10.3.1.      Europe: Market Size and Forecast, By Country, 2023 – 2033 ($ Million)

10.3.2.      Europe: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)

10.3.3.      Europe: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)

10.3.4.      Europe: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)

10.3.5.      U.K.

10.3.5.1.       U.K.: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)

10.3.5.2.       U.K.: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)

10.3.5.3.       U.K.: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)

10.3.6.      GERMANY

10.3.6.1.       Germany: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)

10.3.6.2.       Germany: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)

10.3.6.3.       Germany: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)

10.3.7.      FRANCE

10.3.7.1.       France: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)

10.3.7.2.       France: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)

10.3.7.3.       France: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)

10.3.8.      ITALY

10.3.8.1.       Italy: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)

10.3.8.2.       Italy: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)

10.3.8.3.       Italy: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)

10.3.9.           SPAIN

10.3.9.1.        Spain: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)

10.3.9.2.        Spain: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)

10.3.9.3.        Spain: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)

10.3.10.         BENELUX

10.3.10.1.     BeNeLux: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)

10.3.10.2.     BeNeLux: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)

10.3.10.3.     BeNeLux: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)

10.3.11.         RUSSIA

10.3.11.1.     Russia: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)

10.3.11.2.     Russia: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)

10.3.11.3.     Russia: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)

10.3.12.         REST OF EUROPE

10.3.12.1.     Rest of Europe: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)

10.3.12.2.     Rest of Europe: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)

10.3.12.3.     Rest of Europe: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)

10.4.     Asia Pacific

10.4.1.      Asia Pacific: Market Size and Forecast, By Country, 2023 – 2033 ($ Million)

10.4.2.      Asia Pacific: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)

10.4.3.      Asia Pacific: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)

10.4.4.      Asia Pacific: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)

10.4.5.      CHINA

10.4.5.1.       China: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)

10.4.5.2.       China: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)

10.4.5.3.       China: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)

10.4.6.      JAPAN

10.4.6.1.       Japan: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)

10.4.6.2.       Japan: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)

10.4.6.3.       Japan: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)

10.4.7.      INDIA

10.4.7.1.       India: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)

10.4.7.2.       India: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)

10.4.7.3.       India: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)

10.4.8.      SOUTH KOREA

10.4.8.1.       South Korea: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)

10.4.8.2.       South Korea: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)

10.4.8.3.       South Korea: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)

10.4.9.           THAILAND

10.4.9.1.        Thailand: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)

10.4.9.2.        Thailand: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)

10.4.9.3.        Thailand: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)

10.4.10.         INDONESIA

10.4.10.1.     Indonesia: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)

10.4.10.2.     Indonesia: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)

10.4.10.3.     Indonesia: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)

10.4.11.         MALAYSIA

10.4.11.1.     Malaysia: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)

10.4.11.2.     Malaysia: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)

10.4.11.3.     Malaysia: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)

10.4.12.         AUSTRALIA

10.4.12.1.     Australia: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)

10.4.12.2.     Australia: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)

10.4.12.3.     Australia: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)

10.4.13.         REST FO ASIA PACIFIC

10.4.13.1.     Rest fo Asia Pacific: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)

10.4.13.2.     Rest fo Asia Pacific: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)

10.4.13.3.     Rest fo Asia Pacific: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)

10.5.     South America

10.5.1.      South America: Market Size and Forecast, By Country, 2023 – 2033 ($ Million)

10.5.2.      South America: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)

10.5.3.      South America: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)

10.5.4.      South America: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)

10.5.5.      BRAZIL

10.5.5.1.       Brazil: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)

10.5.5.2.       Brazil: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)

10.5.5.3.       Brazil: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)

10.5.6.      ARGENTINA

10.5.6.1.       Argentina: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)

10.5.6.2.       Argentina: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)

10.5.6.3.       Argentina: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)

10.5.7.      REST OF SOUTH AMERICA

10.5.7.1.       Rest of South America: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)

10.5.7.2.       Rest of South America: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)

10.5.7.3.       Rest of South America: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)

10.6.     Middle East & Africa

10.6.1.      Middle East & Africa: Market Size and Forecast, By Country, 2023 – 2033 ($ Million)

10.6.2.      Middle East & Africa: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)

10.6.3.      Middle East & Africa: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)

10.6.4.      Middle East & Africa: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)

10.6.5.      SAUDI ARABIA

10.6.5.1.       Saudi Arabia: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)

10.6.5.2.       Saudi Arabia: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)

10.6.5.3.       Saudi Arabia: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)

10.6.6.      UAE

10.6.6.1.       UAE: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)

10.6.6.2.       UAE: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)

10.6.6.3.       UAE: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)

10.6.7.      EGYPT

10.6.7.1.       Egypt: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)

10.6.7.2.       Egypt: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)

10.6.7.3.       Egypt: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)

10.6.8.      SOUTH AFRICA

10.6.8.1.       South Africa: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)

10.6.8.2.       South Africa: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)

10.6.8.3.       South Africa: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)

10.6.9.           REST OF MIDDLE EAST & AFRICA

10.6.9.1.        Rest of Middle East & Africa: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)

10.6.9.2.        Rest of Middle East & Africa: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)

10.6.9.3.        Rest of Middle East & Africa: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)

CHAPTER 12.               Competitive Landscape

12.1.     Competitior Benchmarking 2023

12.2.     Market Share Analysis

12.3.     Key Developments Analysis By Top 5 Companies

12.4.     Market Share Acquisition Strategies: Analysis of Key Approaches Employed by Top Players

CHAPTER 13.               Company Profiles

13.1.     Abbott Laboratories

13.1.1.      Business Overview

13.1.2.      Financial Analysis

13.1.2.1.       Business Segment Revenue, 2020, 2021, 2022, $ Million

13.1.2.2.       Geographic Revenue Mix, 2022 (% Share)

13.1.3.      Product Portfolio

13.1.4.      Recent Development and Strategies Adopted

13.1.5.      SWOT Analysis

13.2.     Allergan Plc

13.3.     HOFFMANN-LA ROCHE LTD.

13.4.     GlaxoSmithKline Plc

13.5.     Merck & Co. Inc

13.6.     Mylan N.V

13.7.     Novartis International AG

13.8.     Pfizer Inc

13.9.     Teva Pharmaceutical Industries Ltd.

13.10.   Sanofi

Connect to Analyst

Connect to Analyst

Research Methodology

Research Methodology

Our Most Viewed Report and gain instant expertise

Life Science
$ 3,470.00
$ 5,520.00
$ 1,390.00

Aesthetic Lasers And Energy Devices Market Analysis and Global Forecast 2023-2033

$ 1,390.00 – $ 5,520.00
Aesthetic Lasers And Energy Devices Market Research Report: Information By Product Type (Laser Resurfacing Devices, Body Contouring Devices, Aesthetic Ophthalmology Device and Others), By Technology (Laser-Based Technology, Light-Based Technology and Energy-Based Technology), By Application (Hair Removal, Scar Removal and Skin Resurfacing, Skin Rejuvenation, Skin Tightening, Body Shaping & Skin Tightening and Others), By End User (Multi-Specialty Centers, Standalone Centers, Dermatology Clinics, Ambulatory Surgery Centers (ASCs) and Cosmetic Surgery Centers & Clinics), and by Region — Forecast till 2033 Report Code: EB_LS_320 | Page: 171 | Report Status: Upcoming
Select options This product has multiple variants. The options may be chosen on the product page
Quick view
Life Science
$ 3,470.00
$ 5,520.00
$ 1,390.00

Blood Purification Equipment Market Analysis and Global Forecast 2023-2033

$ 1,390.00 – $ 5,520.00
Blood Purification Equipment Market Research Report: By Product Type (Portable, Stationary), By Indication (Sepsis, Renal Diseases, Others), By End User (Hospitals and Clinics, Dialysis Centers, Others), and by Region — Forecast till 2033 Page: 165
Select options This product has multiple variants. The options may be chosen on the product page
Quick view
Life Science
$ 3,470.00
$ 5,520.00
$ 1,390.00

Clinical Trial Management System Market Analysis and Global Forecast 2023-2033

$ 1,390.00 – $ 5,520.00
Clinical Trial Management System Market Research Report: Information By Product Type (Software, Services), By End User (Medical Device Manufacturers, Small & Mid-sized Pharma-biotech Companies, CROs, Large Pharma-biotech Companies, Other End Users, Other End Users), and by Region — Forecast till 2033 Page: 168
Select options This product has multiple variants. The options may be chosen on the product page
Quick view
Life Science
$ 3,470.00
$ 5,520.00
$ 1,390.00

Gene Therapy Cell Culture Media Market Analysis and Global Forecast 2023-2033

$ 1,390.00 – $ 5,520.00
Gene Therapy Cell Culture Media Market Research Report: Information By Product Type (Media, Viral Vectors), By Application (Biotechnology & Pharmaceutical Industry, Research Laboratory, Academic Institute, Others), and by Region — Forecast till 2033 Page: 164
Select options This product has multiple variants. The options may be chosen on the product page
Quick view
Healthcare
$ 3,470.00
$ 5,520.00
$ 1,390.00

Heart Transplantation Market Analysis and Global Forecast 2023-2033

$ 1,390.00 – $ 5,520.00
Heart Transplantation Market Research Report: Information By Surgery Type (Total Artificial Heart, Biventricular Pacing, Heart Restraint Devices, Ventricular Assist Devices, Other), By End Use (Hospitals, Cardiac institutes, Research Centers, Laboratories, Other), and by Region — Forecast till 2033
Select options This product has multiple variants. The options may be chosen on the product page
Quick view
Life Science
$ 3,470.00
$ 5,520.00
$ 1,390.00

Oncology information systems Market Analysis and Global Forecast 2023-2033

$ 1,390.00 – $ 5,520.00
Oncology information systems Market Research Report: Information By Product (Software, Services), By Application (Radiation Oncology, Medical Oncology, Surgical Oncology), and by Region — Forecast till 2033 Page: 167
Select options This product has multiple variants. The options may be chosen on the product page
Quick view
Life Science
$ 3,470.00
$ 5,520.00
$ 1,390.00

Telmisartan Market Analysis and Global Forecast 2023-2033

$ 1,390.00 – $ 5,520.00

Telmisartan Market Research Report: Information By Indication (Hypertension and Cardiovascular Risk Reduction), By Sales Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, Online Pharmacies), and by Region — Forecast till 2033

Page: 164
Select options This product has multiple variants. The options may be chosen on the product page
Quick view
Life Science
$ 3,470.00
$ 5,520.00
$ 1,390.00

Wearable Patch Market Analysis and Global Forecast 2023-2033

$ 1,390.00 – $ 5,520.00

Wearable Patch Market Research Report: Information By Technology Outlook(Regular Wearable, Connected Wearable), By Application (Clinical, Non-clinical), and by Region — Forecast till 2033.

Page: 153
Select options This product has multiple variants. The options may be chosen on the product page
Quick view